Open Access
Issue
J Oral Med Oral Surg
Volume 26, Number 4, 2020
Article Number 41
Number of page(s) 7
DOI https://doi.org/10.1051/mbcb/2020037
Published online 28 August 2020
  1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45:309–16. [CrossRef] [PubMed] [Google Scholar]
  2. Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8:11884–11894. [PubMed] [Google Scholar]
  3. Ferlay J, Shin H-R, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer J Int Cancer. 2010;127:2893–2917. [Google Scholar]
  4. Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S, Ndiaye C. The global burden of oral diseases and risks to oral health. Bull World Health Organ. 2005;83:661–669. [PubMed] [Google Scholar]
  5. Hussein AA, Helder MN, de Visscher JG, Leemans CR, Braakhuis BJ, de Vet HCW, et al. Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: A systematic review. Eur J Cancer. 2017;82:115–127. [PubMed] [Google Scholar]
  6. Ligier K, Belot A, Launoy G, Velten M, Delafosse P, Guizard AV, et al. Epidemiology of oral cavity cancers in France. Rev Stomatol Chir Maxillofac. 2011;112:164–171. [CrossRef] [PubMed] [Google Scholar]
  7. Moro J da S, Maroneze MC, Ardenghi TM, Barin LM, Danesi CC. Oral and oropharyngeal cancer: epidemiology and survival analysis. Einstein Sao Paulo Braz. 2018;16:eAO4248. [Google Scholar]
  8. Grant E, Silver K, Bauld L, Day R, Warnakulasuriya S. The experiences of young oral cancer patients in Scotland: symptom recognition and delays in seeking professional help. Br Dent J. 2010;208:465–471. [PubMed] [Google Scholar]
  9. Awan KH, Patil S. Efficacy of autofluorescence imaging as an adjunctive technique for examination and detection of oral potentially malignant disorders: a systematic review. J Contemp Dent Pract. 2015;16:744–749. [PubMed] [Google Scholar]
  10. Varela-Centelles P, Estany-Gestal A, Bugarín-González R, Seoane-Romero JM. Oral cancer awareness in Spain: a pilot study. Oral Dis. 2018;24:124–127. [PubMed] [Google Scholar]
  11. Arrivé E, Ligier K, Trouillet M, Harouna AM, Reberdière M de la, Fricain J-C. Revue systématique des facteurs de risque modifiables des cancers de la muqueuse buccale. Médecine Buccale Chir Buccale. 2012;18:25–37. [Google Scholar]
  12. Wong T, Wiesenfeld D. Oral cancer. Aust Dent J. 2018;63:S91–S9. [PubMed] [Google Scholar]
  13. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005;365:1927–1933. [Google Scholar]
  14. Downer MC, Moles DR, Palmer S, Speight PM. A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol. 2004;40:264–273. [PubMed] [Google Scholar]
  15. Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44:10–22. [PubMed] [Google Scholar]
  16. Thomson PJ. Field change and oral cancer: new evidence for widespread carcinogenesis? Int J Oral Maxillofac Surg. 2002;31:262–266. [PubMed] [Google Scholar]
  17. Barrellier P, Babin E, Louis MY, Meunier-Guttin A. The use of toluidine blue in the diagnosis of neoplastic lesions of the oral cavity. Rev Stomatol Chir Maxillofac. 1993;94:51–54. [PubMed] [Google Scholar]
  18. Epstein JB, Gorsky M, Lonky S, Silverman SJ, Epstein JD, Bride M. The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions. Spec Care Dent Off Publ Am Assoc Hosp Dent Acad Dent Handicap Am Soc Geriatr Dent. 2006;26:171–174. [Google Scholar]
  19. Huber MA, Bsoul SA, Terezhalmy GT. Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int. 2004;35:378–384. [PubMed] [Google Scholar]
  20. Poh CF, Ng SP, Williams PM, Zhang L, Laronde DM, Lane P, et al. Direct fluorescence visualization of clinically occult high-risk oral premalignant disease using a simple hand-held device. Head Neck. 2007;29:71–76. [PubMed] [Google Scholar]
  21. Poh CF, Zhang L, Anderson DW, Durham JS, Williams PM, Priddy RW, et al. Fluorescence visualization detection of field alterations in tumor margins of oral cancer patients. Clin Cancer Res Off J Am Assoc Cancer Res. 2006;12:6716–6722. [Google Scholar]
  22. Lane PM, Gilhuly T, Whitehead P, Zeng H, Poh CF, Ng S, et al. Simple device for the direct visualization of oral-cavity tissue fluorescence. J Biomed Opt. 2006;11:024006. [PubMed] [Google Scholar]
  23. Farah CS, McIntosh L, Georgiou A, McCullough MJ. Efficacy of tissue autofluorescence imaging (VELScope) in the visualization of oral mucosal lesions. Head Neck. 2012;34:856–862. [PubMed] [Google Scholar]
  24. Awan KH, Morgan PR, Warnakulasuriya S. Evaluation of an autofluorescence based imaging system (VELscopeTM) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol. 2011;47:274–277. [PubMed] [Google Scholar]
  25. Scheer M, Neugebauer J, Derman A, Fuss J, Drebber U, Zoeller JE. Autofluorescence imaging of potentially malignant mucosa lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111:568–577. [PubMed] [Google Scholar]
  26. Rana M, Zapf A, Kuehle M, Gellrich N-C., Eckardt AM. Clinical evaluation of an autofluorescence diagnostic device for oral cancer detection: a prospective randomized diagnostic study. Eur J Cancer Prev. 2012;21:460–466. [PubMed] [Google Scholar]
  27. Huff K, Stark PC, Solomon LW. Sensitivity of direct tissue fluorescence visualization in screening for oral premalignant lesions in general practice. Gen Dent. 2009;57:34–38. [PubMed] [Google Scholar]
  28. Laronde DM, Williams PM, Hislop TG, Poh C, Ng S, Bajdik C, et al. Influence of fluorescence on screening decisions for oral mucosal lesions in community dental practices. J Oral Pathol Med. 2014;43:7–13. [PubMed] [Google Scholar]
  29. McNamara KK, Martin BD, Evans EW, Kalmar JR. The role of direct visual fluorescent examination (VELscope) in routine screening for potentially malignant oral mucosal lesions. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:636–643. [Google Scholar]
  30. Sawan D, Mashlah A. Evaluation of premalignant and malignant lesions by fluorescent light (VELscope). J Int Soc Prev Community Dent. 2015;5:248–254. [PubMed] [Google Scholar]
  31. Marzouki HZ, Tuong Vi Vu T, Ywakim R, Chauvin P, Hanley J, Kost KM. Use of fluorescent light in detecting malignant and premalignant lesions in the oral cavity: a prospective, single-blind study. J Otolaryngol Head Neck Surg. 2012;41:164–168. [Google Scholar]
  32. Kramer IR, Pindborg JJ, Bezroukov V, Infirri JS. Guide to epidemiology and diagnosis of oral mucosal diseases and conditions. World Health Organization. Community Dent Oral Epidemiol. 1980;8:1–26. [PubMed] [Google Scholar]
  33. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36:575–580. [PubMed] [Google Scholar]
  34. Scully C, Bagan J. Oral squamous cell carcinoma overview. Oral Oncol. 2009;45:301–308. [CrossRef] [PubMed] [Google Scholar]
  35. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med. 2008;37:127–133. [PubMed] [Google Scholar]
  36. Donner A, Shoukri MM, Klar N, Bartfay E. Testing the equality of two dependent kappa statistics. Stat Med. 2000;19:373–387. [PubMed] [Google Scholar]
  37. Barnhart HX, Williamson JM. Weighted least-squares approach for comparing correlated kappa. Biometrics 2002;58:1012–1019. [Google Scholar]
  38. Alonzo TA, Pepe MS, Moskowitz CS. Sample size calculations for comparative studies of medical tests for detecting presence of disease. Stat Med. 2002;21: 835–852. [PubMed] [Google Scholar]
  39. Bossuyt PM, Irwig L, Craig J, Glasziou P. Comparative accuracy: assessing new tests against existing diagnostic pathways. BMJ. 2006;332:1089–1092. [Google Scholar]
  40. Chock C, Irwig L, Berry G, Glasziou P. Comparing dichotomous screening tests when individuals negative on both tests are not verified. J Clin Epidemiol. 1997;50:1211–1217. [PubMed] [Google Scholar]
  41. Pepe MS, Alonzo TA. Comparing disease screening tests when true disease status is ascertained only for screen positives. Biostat Oxf Engl. 2001;2:249–260. [Google Scholar]
  42. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174. [Google Scholar]
  43. Brocklehurst P, Kujan O, Glenny A-M., Oliver R, Sloan P, Ogden G, et al. Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev. 2010:CD004150. [PubMed] [Google Scholar]
  44. Rethman MP, Carpenter W, Cohen EEW, Epstein J, Evans CA, Flaitz CM, et al. Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc. 2010;141:509–520. [PubMed] [Google Scholar]
  45. Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, et al. A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc. 2010;141:151–156. [PubMed] [Google Scholar]
  46. Hanken H, Kraatz J, Smeets R, Heiland M, Assaf AT, Blessmann M, et al. The detection of oral pre- malignant lesions with an autofluorescence based imaging system (VELscopeTM) − a single blinded clinical evaluation. Head Face Med. 2013;9:23. [PubMed] [Google Scholar]
  47. Jané-Salas E, Blanco-Carrión A, Jover-Armengol L, López-López J. Autofluorescence and diagnostic accuracy of lesions of oral mucosa: a pilot study. Braz Dent J. 2015;26:580–586. [PubMed] [Google Scholar]
  48. Ganga RS, Gundre D, Bansal S, Shirsat PM, Prasad P, Desai RS. Evaluation of the diagnostic efficacy and spectrum of autofluorescence of benign, dysplastic and malignant lesions of the oral cavity using VELscope. Oral Oncol. 2017;75:67–74. [PubMed] [Google Scholar]
  49. Scott SE, Rizvi K, Grunfeld EA, McGurk M. Pilot study to estimate the accuracy of mouth self-examination in an at-risk group. Head Neck. 2010;32:1393–1401. [PubMed] [Google Scholar]
  50. Talamini R, Barzan L, Franceschi S, Caruso G, Gasparin A, Comoretto R. Determinants of compliance with an early detection programme for cancer of the head and neck in north-eastern Italy. Eur J Cancer B Oral Oncol. 1994;30B:415–418. [PubMed] [Google Scholar]
  51. Poh CF, Hislop G, Currie B, Lee R, Sikorski S, Zed C, et al. Oral cancer screening in a high-risk underserved community-Vancouver Downtown Eastside. J Health Care Poor Underserved. 2007;18:767–778. [PubMed] [Google Scholar]
  52. Szabó G, Klenk G, Veér A, Németh Z. Correlation of the combination of alcoholism and smoking with the occurrence of cancer in the oral cavity. A screening study in an endangered population. Mund- Kiefer- Gesichtschirurgie MKG. 1999;3:119–122. [Google Scholar]
  53. Harris CK, Warnakulasuriya KAAS, Cooper DJ, Peters TJ, Gelbier S. Prevalence of oral mucosal lesions in alcohol misusers in south London. J Oral Pathol Med. 2004;33:253–259. [CrossRef] [PubMed] [Google Scholar]
  54. Vacher C, Legens M, Rueff B, Lezy JP. Screening of cancerous and precancerous lesions of the oral mucosa in an at-risk population. Rev Stomatol Chir Maxillofac. 1999;100:180–183. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.